The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zabolotskikh I.B.

Kuban State Medical University

Bautin A.E.

Almazov National Medical Research Center

Zamyatin M.N.

National Medical and Surgical Center named after N.I. Pirogov

Lebedinskii K.M.

North-Western State Medical University n.a. Mechnikov, Federal Research;
Clinical Center of Intensive Care Medicine and Rehabilitology

Potievskaya V.I.

Herzen Moscow Research Oncological Institute — Branch of the National Medical Research Center of Radiology

Trembach N.V.

Kuban State Medical University

Perioperative management of patients with heart failure

Authors:

Zabolotskikh I.B., Bautin A.E., Zamyatin M.N., Lebedinskii K.M., Potievskaya V.I., Trembach N.V.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2021;(3): 6‑27

DOI: 10.17116/anaesthesiology20210316

Read: 22798 times

Download PDF (RU)
Contact the author
Table of contents

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEART FAILURE
PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEART FAILURE

To cite this article:

Zabolotskikh IB, Bautin AE, Zamyatin MN, Lebedinskii KM, Potievskaya VI, Trembach NV. Perioperative management of patients with heart failure. Russian Journal of Anesthesiology and Reanimatology. 2021;(3):6‑27. (In Russ.)
https://doi.org/10.17116/anaesthesiology20210316

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Difficult intu­bation risk asse­ssment in bariatric surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):62-68
Features of perioperative period in patients with cardiovascular-kidney-metabolic syndrome. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):26-33
Asse­ssment of real myocardial energy demand using indi­rect calo­rimetry in early postoperative period after cardiac surgery. Piro­gov Russian Journal of Surgery. 2024;(12-2):50-57
A bala­nce between surgical mana­gement and therapy in a patient with severe sternomediastinitis complicated by heart failure and refractory septic shock. Piro­gov Russian Journal of Surgery. 2024;(12-2):166-172
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Inci­dence of diseases of the circulatory system in the working-age popu­lation of the Ural Fede­ral District in 2012—2022. Russian Journal of Preventive Medi­cine. 2025;(1):24-29
Functional state of the kidneys in patients with various types of cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):105-111
Features of gene­ral anesthesia during dental inte­rventions in children with dystrophic epidermolysis bullosa. Stomatology. 2025;(1):63-70
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Abstract:

The guidelines for perioperative management patients with concomitant heart failure are presented in the article. Recent data on epidemiology, pathogenesis, classification and main principles of perioperative management of heart failure are highlighted. Key recommendations on risk stratification and preoperative examination of patients with co-existing heart failure are presented. Peculiarities of anesthesia, intraoperative monitoring and postoperative management of patients with heart failure undergoing non-cardiac surgery are described. Main principles of prophylaxis and treatment of postoperative complications and management of heart failure and acute decompensation syndrome are set out. Basic criteria of medical care quality control are presented.

Keywords:

non-cardiac surgery
preoperative cardiovascular risk stratification
preoperative cardiologic examination
preoperative management cardiovascular diseases
antithrombotic therapy
beta-blockers
valvular diseases
arrhythmias
heart failure
cerebrovascular diseases
anesthesiology
postoperative management cardiovascular diseases

Authors:

Zabolotskikh I.B.

Kuban State Medical University

Bautin A.E.

Almazov National Medical Research Center

Zamyatin M.N.

National Medical and Surgical Center named after N.I. Pirogov

Lebedinskii K.M.

North-Western State Medical University n.a. Mechnikov, Federal Research;
Clinical Center of Intensive Care Medicine and Rehabilitology

Potievskaya V.I.

Herzen Moscow Research Oncological Institute — Branch of the National Medical Research Center of Radiology

Trembach N.V.

Kuban State Medical University

Close metadata

References:

  1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. 
  2. Mareev VYu, Fomin IV, Ageev FT, et al. Clinical guidelines OSSN — RKO — RNMOT. Heart failure: chronic and acute decompensation of heart failure (HF). Kardiologiya. 2018;58(S6):8-164. (In Russ.).
  3. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012;33:1787-1847.
  4. Kristensen SD, Knuuti J, Saraste A, et al; authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and man-agement: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;14(suppl 35):35:2383-2431.
  5. Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KGM, Lammers JW, Cowie MR, Grobbee DE, Hoes AW. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865-2873.
  6. Baumgartner H, Falk V, Bax J, De Bonis M, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;Sep 21;38(36):2739-2791. https://doi.org/10.1093/eurheartj/ehx391
  7. Roizen MF. Anesthestic Implications of Comorbid Diseases. Chapter 35. In: Miller’s Anesthesia. 7th Edition, Churchill Livingstone, 2009.
  8. Biccard BM, Lurati Buse GA, Burkhart C, Cuthbertson BH, Filipovic M, Gibson SC et al. The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia. 2012;67:55-59. 
  9. Rajagopalan S, Croal BL, Reeve J, Bachoo P, Brittenden J. N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up. Eur J Vasc Endovasc Surg. 2011;41:657-662. 
  10. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia. 2008;63:1226-1233.
  11. Moonesinghe SR, Mythen MG, Das P, Rowan KM, Grocott MP. Risk stratification tools for predicting morbidity and mortality in adult patients undergoing major surgery: qualitative systematic review. Anesthesiology. 2013;119:959-981. 
  12. Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic Peptide and N-terminal fragment of pro-B-type natriuretic Peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014;63:170-180. 
  13. Jeger RV, Probst C, Arsenic R, Lippuner T, Pfisterer ME, Seeberger MD et al. Longterm prognostic value of the pre-operative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J. 2006;151:508-513. 
  14. Kazmers A, Cerqueira MD, Zierler RE. Peri-operative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg. 1988;8:307-315. 
  15. Healy KO, Waksmonski CA, Altman RK, Stetson PD, Reyentovich A, Maurer MS. Peri-operative outcomeand long-termmortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. Congest Heart Fail. 2010;16:45-49. 
  16. Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset, Stefan Agewall, Kenneth Dickstein, Thor Edvardsen, Javier Escaned, Bernard J Gersh, Pavel Svitil, Martine Gilard, David Hasdai, Robert Hatala, Felix Mahfoud, Josep Masip, Claudio Muneretto, Marco Valgimigli, Stephan Achenbach, Jeroen J Bax, ESC Scientific Document Group, 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal. 2020;41:3:407-477.  https://doi.org/10.1093/eurheartj/ehz425
  17. Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, Kaiser GC, Alderman E, Ryan TJ, Russell ROJr, Mullin S, Fray D, Killip T3rd. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1982;66:562-568. 
  18. Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH, FortinDF, Stack RS Glower DD, Smith LR et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015-2025.
  19. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979;59:421-430. 
  20. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165-2175.
  21. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2010;55:1416-1424.
  22. Boersma E, Primary Coronary Angioplasty vs Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27(7):779-788. 
  23. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of ardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(22):77-137.  https://doi.org/10.1016/j.jacc.2014.07.944
  24. Fletcher HR, Milhoan LH, Evans K, Austin PN. Patients with aortic stenosis: who should undergo noncardiac surgery in a rural hospital? J Perianesth Nurs. 2013;28:368-376. 
  25. Upshaw J, Kiernan MS. Pre-operative cardiac risk assessment for noncardiac surgery in patients with heart failure. Curr Heart Fail Rep. 2013;10:147-156. 
  26. Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK, Antoniou SA, SerracinoInglott F, et al. A meta-analysis of endovascular vs. surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg. 2013;57:242-253. 
  27. Holte K, Kehlet H. Post-operative ileus: a preventable event. Br J Surg. 2000;87:1480-1493.
  28. Popescu WM, Bell R, Duffy AJ, Katz KH, Perrino AC. A pilot study of patients with clinically severe obesity undergoing laparoscopic surgery: evidence for impaired cardiac performance. J Cardiothorac Vasc Anesth. 2011;25:943-949. 
  29. Lestar M, Gunnarsson L, Lagerstrand L, Wiklund P, Odeberg-Wernerman S. Hemodynamic perturbations during robot-assisted laparoscopic radical prostatectomyin 458 Trendelenburg position. Anesth Analg. 2011;113:1069-1075.
  30. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, ElAllaf D, Vı´tovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Ja´nosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and wellbeing in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive Heart Failure (MERIT-HF). JAMA. 2000;283:1295-1302.
  31. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
  32. Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12-yearsurvival and life expectancy in patients with left ventricular systolic dysfunction: afollow-up study. Lancet. 2003;361:1843-1848.
  33. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. NEngl J Med. 2014;371:993-1004.
  34. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of xtendedrelease metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839-1847.
  35. Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM. Clinical consequences of withholding vs. administering renin-angiotensin-aldosterone system antagonists in the pre-operative period. J Hosp Med. 2008;3:319-325. 
  36. Zannad F, McMurray JJV, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21. 
  37. Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev. 2012;2:CD003838.
  38. King JB, Bress AP, Reese AD, Munger MA. Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review. Pharmacother J Hum Pharmacol Drug Ther. 2015;35:823-837. 
  39. Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. Eur Heart J. 2013;34:886-893. 
  40. Homma S, Thompson JLP, Pullicino PM et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366:1859-1869.
  41. Lip GYH, Ponikowski P, Andreotti F, et al. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail. 2012;14:681-695. 
  42. Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, et al. Standardized Low-Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery An Inception Cohort Management Study. Circulation. 2009;119:2920-2927.
  43. Zabolotskih IB, Kirov MYu, Bozhkova SA, Bulanov AYu, Vorob’eva NA, Grigor’ev EV, Grican AI, Kurapeev IS, Lebedinskij KM, Lomivorotov VV, Ovechkin AM, Potievskaya VI, Sin’kov SV, Subbotin VV, SHulutko EM, Lubnin AYu. Perioperative management of patients undergoing prolonged antithrombotic treatment. Anesteziologiya i reanimatologiya. 2014;4:4-14. (In Russ.).
  44. Toller W, Algotsson L, Guarracino F, et al. Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth. 2013;27:361-366. 
  45. Landoni G, Biondi-Zoccai G, Greco M, et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med. 2012;40(2):634-646.  https://doi.org/10.1097/CCM.0b013e318232962a
  46. Lihvantsev VV, Marchenko DN, Grebenchikov OA, et al. Prevention of heart failure patients with decreased ejection fraction in non-cardiac surgery: levosimendan or anesthetic cardioprotection? Anesteziologiya i reanimatologiya. 2016;61:6:411-417. (In Russ.).
  47. Ponschab M, Hochmair N, Ghazwinian N, et al. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair. Eur J Anaesthesiol. 2008;25(8):627-633. 
  48. Kornienko AN, Dobrushina OR, Zinina EP. Prevention of cardiac complications of extracardiac surgery. Obshch. reanimatol. 2011;VII:5:57-66. (In Russ.).
  49. Khoronenko VE, Mandryka EA, Baskakov DS, Suvorin PA. Adjuvant cardioprotection in thoracic oncosurgery. Anesteziologiya i reanimatologiya. 2019;1:35-43. (In Russ.). https://doi.org/10.17116/anaesthesiology201901135
  50. Xiao-Guang Y, Xia-Guang D, Yu-Ging K. China. The study of myocardial protective effect of creatine phosphate sodium in liver transplant patients. Journal of Modern Medicine. 2013;19:76-78. 
  51. Wen-Long Z, Meng-Fei Y. The myocardial protective effect of sodium phosphocreatine on elderly patients with hip replacement operation. Chinese Journal of Gerontology. 2012;32(2):398-399. 
  52. Landoni G, Zangrillo A, Lomivorotov VV, Likhvantsev V, Ma J, De Simone F, Fominskiy E. Cardiac protection with phosphocreatine: a meta-analysis. Interactive Cardiovascular and Thoracic Surgery. 2016;23:637-647.  https://doi.org/10.1093/icvts/ivw171
  53. Derbugov VN, Potapov AL, Potievskaya VI, Khmelevski YaM. Exogenous phosphocreatine application in elderly and senile patients operated for colorectal cancer. Obshchaya reanimatologiya. 2017;13(4):38-45. (In Russ.). https://doi.org/10.15360/1813-9779-2017-4-38-45
  54. Landoni G, Fochi O, Bignami E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A metaanalysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1:34-43. 
  55. Pagel PS, Farber NE, Wedel DJ. Cardiovascular Pharmacology. In: Miller’sAnaesthesia. Ed. Miller R.D., 2005.
  56. Pirracchio R, Cholley B, De Hert S, Cohen Solal A, Mebazaa A. Diastolic heart failure in anaesthesia and critical care. Br J Anaesth. 2007;98(6):707-721. 
  57. Rodgers A, Walker N, Schug S, et al. Reduction of post-operative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321:1493-1497.
  58. Guay J, Choi P, Suresh S, et al. Neuraxial blockade for the prevention of post-operative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;1:CD010108.
  59. Sakaguchi T, Hirata A, Kashiwase K, Higuchi Y, Ohtani T, Sakata Y, Yasumura Y. Relationship of Central Venous Pressure to Body Fluid Volume Status and Its Prognostic Implication in Patients With Acute Decompensated Heart Failure. J Card Fail. 2018. pii: S1071-9164(18)30209-4. 
  60. Iacoviello M, Puzzovivo A, Monitillo F, Saulle D, Lattarulo MS, Guida P, Forleo C, Gesualdo L, Favale S. Independent role of high central venous pressure in predicting worsening of renal function in chronic heart failure outpatients. Int J Cardiol. 2013;162(3):261-263. Epub 2012 Jul 16.  https://doi.org/10.1016/j.ijcard.2012.06.088
  61. Mohamedali B, Doukky R, Karavalos K, Avery E, Bhat G. Mean Arterial Pressure to Central Venous Pressure Ratio: A Novel Marker for Right Ventricular Failure After Left Ventricular Assist Device Placement. J Card Fail. 2017;23(6):446-452. Epub 2017 Mar 29.  https://doi.org/10.1016/j.cardfail.2017.03.009
  62. van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation. 2011;124:289-296. 
  63. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5-14. 
  64. Mueller H, Chatterjee K, Davis K, et al. Present use of bedside right heart catheterization in patients with cardiac disease. JACC. 1998;32(3):840-864. 
  65. Memtsoudis SG, Rosenberger P, Loffler M, et al. The usefulness of ransesophageal echocardiography during intraoperative cardiac arrest in noncardiac surgery. Anesth Analg. 2006;102:1653-1657.
  66. Shillcutt SK, Markin NW, Montzingo CR, et al. Use of rapid «rescue» perioperative echocardiography to improve outcomes after hemodynamic instability in noncardiac surgical patients. J Cardiothorac Vasc Anesth. 2012;26:362-370. 
  67. Pöpping DM, Elia N, Van Aken HK, et al. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann Surg. 2014;259(6):1056-1067. https://doi.org/10.1097/SLA.0000000000000237
  68. Nishimori M, Low JHS, Zheng H, et al. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2012;7:CD005059.
  69. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA. 1997;277:1127-1134.
  70. Karalapillai D, Story D, Hart GK, et al. Postoperative hypothermia and patient outcomes after major elective noncardiac surgery. Anaesthesia. 2013;68:605-611. 
  71. Wang CS. Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure? JAMA. 2005;294(15):1944.
  72. Bautin AE, Osovskih VV, Basova VA. Echocardiography monitoring. In: Hemodynamics and anesthesia. Edited by Lebedinskiy K.M. SPb.: Chelovek; 2012. (In Russ.).
  73. Seidlerová J, Tůmová P, Rokyta R, Hromadka M. Factors influencing the accuracy of non-invasive blood pressure measurements in patients admitted for cardiogenic shock. BMC Cardiovasc Disord. 2019;19(1):150. PMID: 31215405; PMCID: PMC6582540. https://doi.org/10.1186/s12872-019-1129-9
  74. Green EM, Givertz MM. Management of acute right ventricular failure in theintensive care unit. Curr Heart Fail Rep. 2012;9:228-235. 
  75. Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD009669. https://doi.org/10.1002/14651858.CD009669.pub3. Update in: Cochrane Database Syst Rev. 2020 Nov 5;11:CD009669. PMID: 29376560; PMCID: PMC6491099.
  76. Gautier SV, Poptsov VN, Zakharevich VM, Shevchenko AO, Spirina EA, Ukhrenkov SG, et al. Five-year experience in peripheral venoarterial extracorporeal membrane oxygenation as a method of mechanical circulatory support in potential heart transplant recipients. Russian Journal of Transplantology and Artificial Organs. 2016;18(4):16-25. (In Russ.). https://doi.org/10.1016/j.jacc.2015.07.075
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.